Corrigendum to 'genomic Sequencing Identifies WNK2 As a Driver in Hepatocellular Carcinoma and a Risk Factor for Early Recurrence' [J Hepatol 71 (2019) 1152-63].

Shao-Lai Zhou,Zheng-Jun Zhou,Zhi-Qiang Hu,Cheng-Li Song,Yi-Jie Luo,Chu-Bin Luo,Hao-Yang Xin,Xin-Rong Yang,Ying-Hong Shi,Zheng Wang,Xiao-Wu Huang,Ya Cao,Jia Fan,Jian Zhou
DOI: https://doi.org/10.1016/j.jhep.2022.01.013
IF: 25.7
2022-01-01
Journal of Hepatology
Abstract:Genomic sequencing identifies WNK2 as a driver in hepatocellular carcinoma and a risk factor for early recurrenceJournal of HepatologyVol. 71Issue 6PreviewHepatocellular carcinoma (HCC) is a relatively common type of cancer with rising incidence and mortality rate.1 Approximately half of the 782,500 new cases of liver cancer and the 745,500 deaths due to liver cancer that occur worldwide each year occur in China.1 In China, most HCCs arise from hepatitis B,2 other risk factors such as exposures to aflatoxin3 and aristolochic acids4 can also be important in HCC development. Those etiological factors may result in different genetic alterations, as well as different therapeutic targets, in Chinese patients compared with patients from other countries and regions. Full-Text PDF Open Access It has come to our attention that the supplementary tables for our article were not made available online during the original publication. These have now been uploaded and are available online. We apologize for any inconvenience. The following are the supplementary data to this article: Download .xlsx (1.81 MB) Help with xlsx files Multimedia component 1
What problem does this paper attempt to address?